Efficacy and safety of erythrocytapheresis and low‐dose erythropoietin for treatment of hemochromatosis
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Apheresis"
DOI: 10.1002/jca.21477
Abstract: The aim of this study was to determine retrospectively the efficacy of combined therapy using erythropoietin (EPO) and erythrocytapheresis (EA) in patients with hereditary hemochromatosis (HH) who did not tolerate phlebotomy. read more here.
Keywords: efficacy safety; hemochromatosis; efficacy; erythrocytapheresis low ... See more keywords
Brisk clinical response to erythrocytapheresis in a G6PD‐deficient patient with rasburicase‐induced methemoglobinemia
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Apheresis"
DOI: 10.1002/jca.21540
Abstract: Dear Editor, We read with interest the recent report by Montgomery and Booth, who described a case of methemoglobinemia in a 50-year-old, G6PD-deficient African American man with newly diagnosed T-cell lymphoblastic leukemia being treated with… read more here.
Keywords: range; rasburicase; methemoglobinemia; g6pd deficient ... See more keywords
From total blood exchange to erythrocytapheresis and back to treat complications of sickle cell disease
Sign Up to like & getrecommendations! Published in 2017 at "Transfusion"
DOI: 10.1111/trf.14154
Abstract: Erythrocytapheresis is an important procedure in the management of certain complications of sickle cell disease, including acute stroke, stroke prevention, acute chest syndrome, and multiorgan failure. Erythrocytapheresis in sickle cell disease simply entails the removal… read more here.
Keywords: complications sickle; cell disease; erythrocytapheresis; cell ... See more keywords